Universitätsklinikum Frankfurt Goethe-Universität

Frankfurt 60590

3 studies enrolling now · 8 studies all time

What they study most

Aortic Stenosis, Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Crohn's Disease, Hereditary Angioedema, Metabolic Dysfunction-Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Obesity, Obesity or Overweight, Overweight, Ulcerative Colitis

Studies at this site

• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Recruiting now
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• PERIGON Pivotal Trial — Running, not enrolling
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE) — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early